O

OMEGA PHARMA INNOVATION & DEVELOPMENT (Public limited company)

Omega Pharma Innovation & Development
BE 0884.084.724 Active ●Gaston Crommenlaan 6, 9050 Gand

OMEGA PHARMA INNOVATION & DEVELOPMENT is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0884.084.724. It was founded on 09-10-2006. Its registered office is in Ghent. Its main activity is: Scientific research and development. Its annual accounts for 2025 report equity of € 240 227 970 and a profit of € 11 369 901. These accounts report 38.2 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 3 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0884.084.724
VAT registered
Yes
Founded
09-10-2006
Latest accounts
2025
Employees
38.2 FTE
Region
Flanders
Establishments
1
Filing record
On time 3 of 3 years
Peppol e-invoicing
Registered
Registered office
Gaston Crommenlaan 6, 9050 Gand
Main activity
Scientific research and development
NACE activities
72109 Recherche-développement en autres sciences physiques et naturelles
72101 Recherche-développement en biotechnologie

Key figures of OMEGA PHARMA INNOVATION & DEVELOPMENT

20252023
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 11 369 901€ 9 744 434
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 240 227 970€ 124 642 527
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 246 592 735€ 152 759 583
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
--
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
38.243.1

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
6 mandates on record in the annual accounts. 3 of them started since 2024.
Create a free account

Similar companies

Other companies in the same activity in Ghent.

CompanyTown
FENIKX 9050 Gent
FERMEDICS 9050 Gent
CODEVID 9050 Gent
CLOUDS OF CARE 9050 Gent
Bart Bot Archeologie 9050 Gent
IndusFilter 9050 Gent
DE KOPPELING 9050 Gent
TRIPTOLEMUS 9050 Gent
Looking for more information about OMEGA PHARMA INNOVATION & DEVELOPMENT?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is OMEGA PHARMA INNOVATION & DEVELOPMENT still active? Yes. The Crossroads Bank for Enterprises lists OMEGA PHARMA INNOVATION & DEVELOPMENT as active.

What is the VAT number of OMEGA PHARMA INNOVATION & DEVELOPMENT? The VAT number of OMEGA PHARMA INNOVATION & DEVELOPMENT is BE 0884.084.724.

When was OMEGA PHARMA INNOVATION & DEVELOPMENT founded? OMEGA PHARMA INNOVATION & DEVELOPMENT was founded on 09-10-2006.

What is the address of OMEGA PHARMA INNOVATION & DEVELOPMENT? The current registered office of OMEGA PHARMA INNOVATION & DEVELOPMENT is Gaston Crommenlaan 6, 9050 Gand.

When did OMEGA PHARMA INNOVATION & DEVELOPMENT last file annual accounts? The latest annual accounts of OMEGA PHARMA INNOVATION & DEVELOPMENT were filed on 07-07-2026.

Does OMEGA PHARMA INNOVATION & DEVELOPMENT file its annual accounts on time? Yes. OMEGA PHARMA INNOVATION & DEVELOPMENT filed its annual accounts within the legal deadline for each of its last 3 financial years.

How many employees does OMEGA PHARMA INNOVATION & DEVELOPMENT have? OMEGA PHARMA INNOVATION & DEVELOPMENT employs 38.2 full-time equivalents according to its most recent annual accounts.

Is OMEGA PHARMA INNOVATION & DEVELOPMENT financially healthy? Addrly gives OMEGA PHARMA INNOVATION & DEVELOPMENT a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is OMEGA PHARMA INNOVATION & DEVELOPMENT profitable? The annual accounts of OMEGA PHARMA INNOVATION & DEVELOPMENT for 2025 show a profit of € 11 369 901.

What is the equity of OMEGA PHARMA INNOVATION & DEVELOPMENT? The equity of OMEGA PHARMA INNOVATION & DEVELOPMENT was € 240 227 970 at the close of the 2025 financial year.

Who are the directors of OMEGA PHARMA INNOVATION & DEVELOPMENT? The annual accounts of OMEGA PHARMA INNOVATION & DEVELOPMENT record 6 mandates. The names, roles and dates are visible with a free account.

Can OMEGA PHARMA INNOVATION & DEVELOPMENT receive Peppol e-invoices? Yes. OMEGA PHARMA INNOVATION & DEVELOPMENT is registered on the Peppol network and can receive structured electronic invoices.

What does OMEGA PHARMA INNOVATION & DEVELOPMENT do? The main activity of OMEGA PHARMA INNOVATION & DEVELOPMENT is: Scientific research and development.

Sources

How Addrly builds and refreshes this data